U.K. Regulators Urge People With Severe Allergies To Avoid Pfizer Coronavirus Vaccine After 2 HCWs Experience Reactions

Wall Street Journal: Two in U.K. Suffer Allergic Reaction to Pfizer’s Covid-19 Vaccine
“Two of the first people vaccinated in the U.K. on Tuesday with the Pfizer Inc.-BioNTech SE shot responded adversely to the injection, the country’s National Health Service said, prompting the regulator to issue new guidance warning those with a history of significant allergic reactions against having the inoculation. … The two people are NHS workers, part of the first tranche to receive the vaccine in line with front-line staff having initial access. Each of them carried an adrenaline auto-injector to deal with their allergies. … The agency said that the vaccine, which is administered in two doses at least 21 days apart, had triggered an anaphylactoid reaction in the two people shortly after they received the shot. Such reactions are triggered sometimes by drugs such as aspirin, certain anti-inflammatory drugs, and opiates…” (Sugden, 12/9).

Additional coverage of the U.K. regulators’ warning is available from AP, Financial Times, New York Times, and TIME.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.